Appropriateness of the 30-day expected mortality metric in palliative radiation treatment: a narrative review
Inmaculada Navarro-Domenech(Princess Margaret Cancer Centre), Srinivas Raman(Princess Margaret Cancer Centre), Abram Recht(Beth Israel Deaconess Medical Center), Yvette M. van der Linden(Leiden University Medical Center), Peter Hoskin(University of Manchester), Johan Menten(Catholic University of America), Edward Chow(Sunnybrook Health Science Centre), Eva Oldenburger(KU Leuven), Nicolaus Andratschke(University Hospital of Zurich), Mateusz Spałek(National Institute of Oncology), Charles B. Simone(New York Proton Center), Jonas Willmann(Memorial Sloan Kettering Cancer Center), Tara Behroozian(McMaster University), Quynh‐Nhu Nguyen(The University of Texas MD Anderson Cancer Center), Candice Johnstone(Medical College of Wisconsin), Gustavo Nader Marta(Eastern Cooperative Oncology Group), Stephen Lutz(Unknown), Lauren Milton(Health Sciences Centre), Joanna Kaźmierska(Poznan University of Medical Sciences), Peter A.S. Johnstone(Moffitt Cancer Center), Joanne M. van der Velden(Leiden University Medical Center)
Cited by 14
Related Papers
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
|Journal of Clinical Oncology|2001|819